Table 1.
Models | Transitions HR (95% CI) | |||
---|---|---|---|---|
Absent to present | Absent to death | Present to absent | Present to death | |
DN† | N = 129 | N = 30 | N = 85 | N = 83 |
sRAGE (per 0.2 log pg/mL) | 1.10 (1.03, 1.18)* | 0.73 (0.56, 0.94)* | 0.82 (0.75, 0.89)* | 1.12 (1.06, 1.19)* |
Duration (per 5 years) | 1.23 (1.13, 1.35)* | 1.48 (1.13, 1.95)* | 0.93 (0.81, 1.07) | 1.44 (1.32, 1.57)* |
Age at diagnosis (per 5 years) | 1.15 (1.03, 1.28)* | 1.35 (0.85, 2.12) | 1.12 (0.95, 1.31) | 1.17 (1.03, 1.33)* |
HbA1c (per 1%) | 1.44 (1.29, 1.62)* | 1.01 (0.41, 2.47) | 1.04 (0.90, 1.19) | 1.23 (1.10, 1.37)* |
CKD‡ | N = 102 | N = 41 | N = 22 | N = 45 |
sRAGE (per 0.2 log pg/mL) | 1.38 (1.25, 1.52)* | 0.85 (0.70, 1.04) | 1.15 (0.95, 1.40) | 1.22 (1.11, 1.34)* |
Duration (per 5 years) | 1.42 (1.27, 1.59)* | 1.43 (1.17, 1.75)* | 0.90 (0.69, 1.17) | 1.57 (1.38, 1.80)* |
Age at diagnosis (per 5 years) | 1.39 (1.20, 1.62)* | 0.97 (0.72, 1.32) | 1.77 (1.25, 2.51)* | 1.24 (1.04, 1.48)* |
HbA1c (per 1%) | 1.52 (1.32, 1.75)* | 1.52 (1.16, 1.99)* | 1.01 (0.72, 1.41) | 1.28 (1.08, 1.53)* |
MABP (per 5 mmHg) | 1.15 (1.04, 1.26)* | 1.03 (0.83, 1.26) | 0.87 (0.69, 1.09) | 1.01 (0.90, 1.13) |
Sex (male) | 0.46 (0.29, 0.71)* | 1.20 (0.52, 2.77) | 0.23 (0.08, 0.68)* | 1.62 (0.93, 2.79) |
Proteinuria‡ | N = 97 | N = 43 | N = 84 | N = 43 |
sRAGE (per 0.2 log pg/mL) | 1.07 (0.97, 1.18) | 0.98 (0.76, 1.25) | 0.90 (0.81, 0.98)* | 1.19 (1.06, 1.33)* |
Duration (per 5 years) | 1.16 (1.03, 1.30)* | 1.56 (1.26, 1.93)* | 1.05 (0.90, 1.22) | 1.70 (1.46, 1.98)* |
Age at diagnosis (per 5 years) | 0.86 (0.74, 1.00) | 1.24 (0.84, 1.82) | 0.93 (0.78, 1.11) | 1.25 (1.03, 1.51)* |
HbA1c (per 1%) | 1.43 (1.24, 1.64)* | 1.05 (0.57, 1.93) | 0.97 (0.81, 1.17) | 1.38 (1.10, 1.73)* |
MABP (per 5 mmHg) | 1.16 (1.04, 1.29)* | 0.98 (0.74, 1.30) | 0.98 (0.87, 1.10) | 0.96 (0.85, 1.09) |
Smoking status (current) | 2.18 (1.38, 3.43)* | 1.95 (0.72, 5.27) | 1.38 (0.81, 2.34) | 1.26 (0.71, 2.25) |
DN† | N = 129 | N = 30 | N = 85 | N = 83 |
CML (per 0.2 log pg/mL) | 1.04 (0.97, 1.11) | 0.50 (0.34, 0.73)* | 1.07 (0.97, 1.17) | 1.08 (1.01, 1.16)* |
Duration (per 5 years) | 1.24 (1.14, 1.35)* | 1.45 (1.10, 1.91)* | 0.92 (0.80, 1.05) | 1.48 (1.36, 1.62)* |
Age at diagnosis (per 5 years) | 1.15 (1.03, 1.28)* | 1.67 (0.98, 2.86) | 1.11 (0.94, 1.30) | 1.13 (0.99, 1.29) |
HbA1c (per 1%) | 1.45 (1.30, 1.61)* | 0.97 (0.60, 1.56) | 1.03 (0.90, 1.18) | 1.21 (1.10, 1.34)* |
CKD‡ | N = 102 | N = 41 | N = 22 | N = 45 |
CML (per 0.2 log pg/mL) | 1.04 (0.93, 1.16) | 0.72 (0.55, 0.94)* | 1.35 (1.10, 1.66)* | 1.12 (1.00, 1.25)* |
Duration (per 5 years) | 1.42 (1.28, 1.58)* | 1.38 (1.11, 1.73)* | 0.87 (0.67, 1.13) | 1.53 (1.35, 1.75)* |
Age at diagnosis (per 5 years) | 1.44 (1.25, 1.66)* | 0.84 (0.58, 1.21) | 1.54 (1.07, 2.22)* | 1.30 (1.09, 1.55)* |
HbA1c (per 1%) | 1.41 (1.23, 1.63)* | 1.76 (1.31, 2.35)* | 0.92 (0.64, 1.32) | 1.15 (0.96, 1.37) |
MABP (per 5 mmHg) | 1.09 (0.99, 1.19) | 1.13 (0.92, 1.39) | 0.82 (0.66, 1.02) | 1.02 (0.92, 1.14) |
Sex (male) | 0.50 (0.33, 0.75)* | 1.36 (0.51, 3.63) | 0.51 (0.18, 1.47) | 1.34 (0.80, 2.25) |
Proteinuria‡ | N = 97 | N = 43 | N = 84 | N = 43 |
CML (per 0.2 log pg/mL) | 1.00 (0.92, 1.09) | 0.59 (0.27, 1.31) | 0.98 (0.88, 1.09) | 1.05 (0.94, 1.17) |
Duration (per 5 years) | 1.17 (1.06, 1.30)* | 1.48 (1.13, 1.95)* | 0.99 (0.86, 1.15) | 1.76 (1.51, 2.04)* |
Age at diagnosis (per 5 years) | 0.87 (0.76, 1.00) | 1.56 (0.59, 4.11) | 0.93 (0.78, 1.09) | 1.17 (0.97, 1.41) |
HbA1c (per 1%) | 1.44 (1.26, 1.65)* | 0.98 (0.47, 2.05) | 1.02 (0.86, 1.22) | 1.30 (1.09, 1.56)* |
MABP (per 5 mmHg) | 1.14 (1.03, 1.27)* | 0.78 (0.44, 1.38) | 0.97 (0.87, 1.08) | 1.02 (0.89, 1.16) |
Smoking status (current) | 2.15 (1.38, 3.33)* | 1.84 (0.40, 8.36) | 1.43 (0.86, 2.40) | 1.31 (0.75, 2.27) |
Our MSM models have three states: 1) disease present, 2) disease absent, and 3) death. Transitions between states are simultaneously modeled, resulting in four transitions. MABP, mean arterial blood pressure.
Statistically significant associations; P value <0.05.
Defined as either the presence of proteinuria, CKD, dialysis, or renal transplant.
Excludes cases with dialysis or renal transplant.